Sage Journals: Discover world-class research

Retricted access

Research article

First published 2011-07

Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma – a 7.5-year follow-up study

Sanda Jelisavac-Cosic, Maja Sirotkovic-Skerlev, Ana Kulic [...]

Tumori Journal

Free access

Research article

First published 2004-8

Attenuation of Neointimal Vascular Smooth Muscle Cellularity in Atheroma by Plasminogen Activator Inhibitor Type 1 (PAI-1)

David J. Schneider, Michael Hayes, Marilyn Wadsworth [...]

Journal of Histochemistry & Cytochemistry

Retricted access

Research article

First published 2008-09

Investigation of Association between Plasminogen Activator Inhibitor Type-1 ( PAI-1 ) Gene 4G/5G Polymorphism Frequency and Plasma PAI-1 Enzyme Activity in Patients with Acute Stroke

Banu Kucukarabaci, Hasan Veysi Gunes, Gazi Ozdemir [...]

Genetic Testing and Molecular Biomarkers

Retricted access

Review article

First published 1999-7

Thrombin Upregulates Production of Plasminogen Activator Inhibitor Type 1 in Human Peritoneal Mesothelial Cells

Sonja Mandl–Weber, Bettina Haslinger, Thomas Sitter

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Retricted access

Other

First published 2009-3

A Profibrotic Effect of Plasminogen Activator Inhibitor Type-1 (PAI-1) in the Heart

A. K. M. Tarikuz Zaman, Christopher J. French, David J. Schneider [...]

Experimental Biology and Medicine

Retricted access

Research article

First published 2001-9

Early Glycated Albumin,but Not Advanced Glycated Albumin,Methylglyoxal,or 3-Deoxyglucosone Increases the Expression of Pai-1 in Human Peritoneal Mesothelial Cells

Sonja Mandl–Weber, Bettina Haslinger, Casper G. Schalkwijk [...]

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Retricted access

Research article

First published 1998-04

Plasminogen Activator Inhibitor Type-1 (PAI-1) Levels Are Decreased in NIDDM Patients treated with Insulin

Peter Galajda, Emil Martinka, Ján Staško [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2024-2

Circulating miR-10b,soluble urokinase-type plasminogen activator receptor,and plasminogen activator inhibitor-1 as predictors of non-small cell lung cancer progression and treatment response

Lyana Setiawan, Rahajuningsih Setiabudy, Siti Boedina Kresno [...]

Cancer Biomarkers

Free access

Research article

First published 2003-04

Prognostic and Predictive value of the Urokinase-Type Plasminogen Activator (uPA) and Its Inhibitors PAI-1 and PAI-2 in Operable Breast Cancer

T. Cufer, S. Borstnar, I. Vrhovec

The International Journal of Biological Markers

Retricted access

Research article

First published 1997-1

A Sensitive and Robust Assay for Urokinase and Tissue-Type Plasminogen Activators (Upa and Tpa) and Their Inhibitor Type I (Pai-1) in Breast Tumor Cytosols

N. Grebenschikov, A. Geurts-Moespot, H. De Witte [...]

The International Journal of Biological Markers

Search results